The EHA Research Roadmap: Malignant Lymphoid Diseases

J 2022

The EHA Research Roadmap: Malignant Lymphoid Diseases

DREYLING, Martin, Marc ANDRE, Nicola GOKBUGET, Herve TILLY, Mats JERKEMAN et. al.

Basic information

Original name

The EHA Research Roadmap: Malignant Lymphoid Diseases

Authors

DREYLING, Martin (guarantor), Marc ANDRE, Nicola GOKBUGET, Herve TILLY, Mats JERKEMAN, John GRIBBEN, Andres FERRERI, Pierre MOREL, Stephan STILGENBAUER, Christopher FOX, Maria Ribera JOSE, Sonja ZWEEGMAN, Igor AURER, Csaba BODOR, Birgit BURKHARDT, Christian BUSKE, Dollores Caballero MARIA, Elias CAMPO, Bjoern CHAPUY, Andrew DAVIES, de Leval LAURENCE, Jeanette DOORDUIJN, Massimo FEDERICO, Philippe GAULARD, Francesca GAY, Paolo GHIA, Kirsten GRONBAEK, Hartmut GOLDSCHMIDT, Marie-Jose KERSTEN, Barbara KIESEWETTER, Judith LANDMAN-PARKER, Le Gouill STEVEN, Georg LENZ, Sirpa LEPPA, Armando LOPEZ-GUILLERMO, Elizabeth MACINTYRE, Maria Victoria Mateos MANTEGA, Philippe MOREAU, Carol MORENO, Bertrand NADEL, Jessica OKOSUN, Roger OWEN, Šárka POSPÍŠILOVÁ (203 Czech Republic, belonging to the institution), Christiane POTT, Tadeusz ROBAK, Michelle SPINA, Kostas STAMATOPOULOS, Jan STARY, Karin TARTE, Allessandra TEDESCHI, Catherine THIEBLEMONT, Ralf Ulrich TRAPPE, Lorenz H TRUMPER and Gilles SALLES

Edition

HemaSphere, Philadelphia, Lippincott Williams & Wilkins, 2022, 2572-9241

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30205 Hematology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 6.600

RIV identification code

RIV/00216224:14110/22:00126413

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1097/HS9.0000000000000726

UT WoS

000797600900001

Keywords in English

Malignant Lymphoid Diseases; EHA Research Roadmap

Abstract

V originále

In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research aiming to highlight achievements in the diagnostics and treatment of blood disorders and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1 to 2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including 11 sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent priorities in hematology research and clinical science, therefore supporting a more informed, focused, and ideally a more funded future for European hematology research. The 11 EHA Research Roadmap sections include Normal Hematopoiesis; Malignant Lymphoid Diseases; Malignant Myeloid Diseases; Anemias and Related Diseases; Platelet Disorders; Blood Coagulation and Hemostatic Disorders; Transfusion Medicine; Infections in Hematology; Hematopoietic Stem Cell Transplantation; CAR-T and Other Cell-based Immune Therapies; and Gene Therapy.

Citovat

DREYLING, Martin, Marc ANDRE, Nicola GOKBUGET, Herve TILLY, Mats JERKEMAN, John GRIBBEN, Andres FERRERI, Pierre MOREL, Stephan STILGENBAUER, Christopher FOX, Maria Ribera JOSE, Sonja ZWEEGMAN, Igor AURER, Csaba BODOR, Birgit BURKHARDT, Christian BUSKE, Dollores Caballero MARIA, Elias CAMPO, Bjoern CHAPUY, Andrew DAVIES, de Leval LAURENCE, Jeanette DOORDUIJN, Massimo FEDERICO, Philippe GAULARD, Francesca GAY, Paolo GHIA, Kirsten GRONBAEK, Hartmut GOLDSCHMIDT, Marie-Jose KERSTEN, Barbara KIESEWETTER, Judith LANDMAN-PARKER, Le Gouill STEVEN, Georg LENZ, Sirpa LEPPA, Armando LOPEZ-GUILLERMO, Elizabeth MACINTYRE, Maria Victoria Mateos MANTEGA, Philippe MOREAU, Carol MORENO, Bertrand NADEL, Jessica OKOSUN, Roger OWEN, Šárka POSPÍŠILOVÁ, Christiane POTT, Tadeusz ROBAK, Michelle SPINA, Kostas STAMATOPOULOS, Jan STARY, Karin TARTE, Allessandra TEDESCHI, Catherine THIEBLEMONT, Ralf Ulrich TRAPPE, Lorenz H TRUMPER and Gilles SALLES. The EHA Research Roadmap: Malignant Lymphoid Diseases. HemaSphere. Philadelphia: Lippincott Williams & Wilkins, 2022, vol. 6, No 6, p. 1-18. ISSN 2572-9241. Available from: https://dx.doi.org/10.1097/HS9.0000000000000726.

@article{2211019,
   author = {Dreyling, Martin and Andre, Marc and Gokbuget, Nicola and Tilly, Herve and Jerkeman, Mats and Gribben, John and Ferreri, Andres and Morel, Pierre and Stilgenbauer, Stephan and Fox, Christopher and Jose, Maria Ribera and Zweegman, Sonja and Aurer, Igor and Bodor, Csaba and Burkhardt, Birgit and Buske, Christian and Maria, Dollores Caballero and Campo, Elias and Chapuy, Bjoern and Davies, Andrew and Laurence, de Leval and Doorduijn, Jeanette and Federico, Massimo and Gaulard, Philippe and Gay, Francesca and Ghia, Paolo and Gronbaek, Kirsten and Goldschmidt, Hartmut and Kersten, MarieandJose and Kiesewetter, Barbara and LandmanandParker, Judith and Steven, Le Gouill and Lenz, Georg and Leppa, Sirpa and LopezandGuillermo, Armando and Macintyre, Elizabeth and Mantega, Maria Victoria Mateos and Moreau, Philippe and Moreno, Carol and Nadel, Bertrand and Okosun, Jessica and Owen, Roger and Pospíšilová, Šárka and Pott, Christiane and Robak, Tadeusz and Spina, Michelle and Stamatopoulos, Kostas and Stary, Jan and Tarte, Karin and Tedeschi, Allessandra and Thieblemont, Catherine and Trappe, Ralf Ulrich and Trumper, Lorenz H and Salles, Gilles},
   article_location = {Philadelphia},
   article_number = {6},
   doi = {http://dx.doi.org/10.1097/HS9.0000000000000726},
   keywords = {Malignant Lymphoid Diseases; EHA Research Roadmap},
   language = {eng},
   issn = {2572-9241},
   journal = {HemaSphere},
   title = {The EHA Research Roadmap: Malignant Lymphoid Diseases},
   url = {https://journals.lww.com/hemasphere/Fulltext/2022/06000/The_EHA_Research_Roadmap__Malignant_Lymphoid.10.aspx},
   volume = {6},
   year = {2022}
}

TY  - JOUR
ID  - 2211019
AU  - Dreyling, Martin - Andre, Marc - Gokbuget, Nicola - Tilly, Herve - Jerkeman, Mats - Gribben, John - Ferreri, Andres - Morel, Pierre - Stilgenbauer, Stephan - Fox, Christopher - Jose, Maria Ribera - Zweegman, Sonja - Aurer, Igor - Bodor, Csaba - Burkhardt, Birgit - Buske, Christian - Maria, Dollores Caballero - Campo, Elias - Chapuy, Bjoern - Davies, Andrew - Laurence, de Leval - Doorduijn, Jeanette - Federico, Massimo - Gaulard, Philippe - Gay, Francesca - Ghia, Paolo - Gronbaek, Kirsten - Goldschmidt, Hartmut - Kersten, Marie-Jose - Kiesewetter, Barbara - Landman-Parker, Judith - Steven, Le Gouill - Lenz, Georg - Leppa, Sirpa - Lopez-Guillermo, Armando - Macintyre, Elizabeth - Mantega, Maria Victoria Mateos - Moreau, Philippe - Moreno, Carol - Nadel, Bertrand - Okosun, Jessica - Owen, Roger - Pospíšilová, Šárka - Pott, Christiane - Robak, Tadeusz - Spina, Michelle - Stamatopoulos, Kostas - Stary, Jan - Tarte, Karin - Tedeschi, Allessandra - Thieblemont, Catherine - Trappe, Ralf Ulrich - Trumper, Lorenz H - Salles, Gilles
PY  - 2022
TI  - The EHA Research Roadmap: Malignant Lymphoid Diseases
JF  - HemaSphere
VL  - 6
IS  - 6
SP  - 1-18
EP  - 1-18
PB  - Lippincott Williams & Wilkins
SN  - 25729241
KW  - Malignant Lymphoid Diseases
KW  - EHA Research Roadmap
UR  - https://journals.lww.com/hemasphere/Fulltext/2022/06000/The_EHA_Research_Roadmap__Malignant_Lymphoid.10.aspx
N2  - In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research aiming to highlight achievements in the diagnostics and treatment of blood disorders and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1 to 2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including 11 sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent priorities in hematology research and clinical science, therefore supporting a more informed, focused, and ideally a more funded future for European hematology research. The 11 EHA Research Roadmap sections include Normal Hematopoiesis; Malignant Lymphoid Diseases; Malignant Myeloid Diseases; Anemias and Related Diseases; Platelet Disorders; Blood Coagulation and Hemostatic Disorders; Transfusion Medicine; Infections in Hematology; Hematopoietic Stem Cell Transplantation; CAR-T and Other Cell-based Immune Therapies; and Gene Therapy.
ER  -

DREYLING, Martin, Marc ANDRE, Nicola GOKBUGET, Herve TILLY, Mats JERKEMAN, John GRIBBEN, Andres FERRERI, Pierre MOREL, Stephan STILGENBAUER, Christopher FOX, Maria Ribera JOSE, Sonja ZWEEGMAN, Igor AURER, Csaba BODOR, Birgit BURKHARDT, Christian BUSKE, Dollores Caballero MARIA, Elias CAMPO, Bjoern CHAPUY, Andrew DAVIES, de Leval LAURENCE, Jeanette DOORDUIJN, Massimo FEDERICO, Philippe GAULARD, Francesca GAY, Paolo GHIA, Kirsten GRONBAEK, Hartmut GOLDSCHMIDT, Marie-Jose KERSTEN, Barbara KIESEWETTER, Judith LANDMAN-PARKER, Le Gouill STEVEN, Georg LENZ, Sirpa LEPPA, Armando LOPEZ-GUILLERMO, Elizabeth MACINTYRE, Maria Victoria Mateos MANTEGA, Philippe MOREAU, Carol MORENO, Bertrand NADEL, Jessica OKOSUN, Roger OWEN, Šárka POSPÍŠILOVÁ, Christiane POTT, Tadeusz ROBAK, Michelle SPINA, Kostas STAMATOPOULOS, Jan STARY, Karin TARTE, Allessandra TEDESCHI, Catherine THIEBLEMONT, Ralf Ulrich TRAPPE, Lorenz H TRUMPER and Gilles SALLES. The EHA Research Roadmap: Malignant Lymphoid Diseases. \textit{HemaSphere}. Philadelphia: Lippincott Williams \&{} Wilkins, 2022, vol.~6, No~6, p.~1-18. ISSN~2572-9241. Available from: https://dx.doi.org/10.1097/HS9.0000000000000726.

Detailed Information on Publication Record